Mingbo Cao
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Cancer Cells and Metastasis
Papers in
-
- Cancer-related molecular mechanisms research 4
- Cancer, Lipids, and Metabolism 3
- MicroRNA in disease regulation 2
-
- Gastrointestinal motility and disorders 2
- Co-authors
- Yuzhuo WangDaniel SudilovskyYun K. HomBaohui ZhangGerald R. CunhaGary D. GrossfeldSimon W. HaywardShuangyin Han
- Journals
- Aging (1 paper)Chinese Journal of Integrative Medicine (1 paper)Frontiers in Medicine (1 paper)Non-coding RNA Research (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Mingbo Cao
12 papers receiving 425 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 104
- Oncology 140
- Gastroenterology 24
- Pulmonary and Respiratory Medicine 140
- Molecular Biology 205
Countries citing papers authored by Mingbo Cao
This map shows the geographic impact of Mingbo Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingbo Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingbo Cao more than expected).
Fields of papers citing papers by Mingbo Cao
This network shows the impact of papers produced by Mingbo Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingbo Cao. The network helps show where Mingbo Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingbo Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2021 | 38 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 18 | |
| 7 | The effect of polyene phosphatidyl choline intervention on nonalcoholic steatohepatitis and related mechanism. | 2016 | 29 |
| 8 | 2008 | 7 | |
| 9 | [An experimental study on the expression and pathogenic effects of cyclooxygenase-2 in nonalcoholic fatty liver disease]. | 2008 | 1 |
| 10 | 2007 | 4 | |
| 11 | 2007 | 31 | |
| 12 | 2007 | 1 | |
| 13 | Malignant transformation in a nontumorigenic human prostatic epithelial cell line. | 2001 | 287 |
| 14 | [Orthogonal design-direct analysis for PCR optimization]. | 1998 | 8 |
About Mingbo Cao
Mingbo Cao is a scholar working on Cancer Research, Gastroenterology, Biochemistry, Pharmacology and Pharmacology, having authored 14 papers that have together received 430 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Cancer, Lipids, and Metabolism (3 papers), Gastrointestinal motility and disorders (2 papers), Circular RNAs in diseases (2 papers), Inflammatory mediators and NSAID effects (2 papers), MicroRNA in disease regulation (2 papers) and Microbial Metabolites in Food Biotechnology (1 paper). The work is most often cited by research in Cancer Research (104 citations), Oncology (140 citations), Gastroenterology (24 citations), Pulmonary and Respiratory Medicine (140 citations) and Molecular Biology (205 citations). Mingbo Cao has collaborated with scholars based in China and United States. Frequent co-authors include Yuzhuo Wang, Daniel Sudilovsky, Yun K. Hom, Baohui Zhang, Gerald R. Cunha, Gary D. Grossfeld, Simon W. Hayward, Shuangyin Han, Baicang Zou and Lei Dong. Their work appears in journals such as Aging, Chinese Journal of Integrative Medicine, Frontiers in Medicine, Non-coding RNA Research and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.